The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction.
The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction.
复制标题
DOI:
10.1093/ehjopen/oeac028
复制
发表时间:
2022-05
期刊:
影响因子:
--
通讯作者:
Galkina, Elena V
中科院分区:
文献类型:
--
作者:
Keeter, William Coles;Carter, Nigeste M;Nadler, Jerry L;Galkina, Elena V
Mouse models with genetic modifications are required to investigate atherogenesis and associated metabolic syndrome. Adeno-associated virus-8 (AAV8)-mediated overexpression of PCSK9 (AAV8-PCSK9) induces hyperlipidaemia and promotes atherosclerosis in C57BL/6 mice. We aimed to assess whether AAV8-PCSK9-injected C57BL/6 mice fed high-fat diet with added cholesterol (HFD-C) would serve as a model of combined metabolic syndrome and atherosclerosis. C57BL/6 mice received i.v. injection of AAV-PCSK9 and sex- and age-matched Ldlr−/− and C57BL/6 control mice were placed on HFD-C or chow diet for 20 weeks (B6-PCSK9-HFD-C, Ldlr−/− HFD-C, B6-HFD-C, and B6-Chow, respectively). High-fat diet with added cholesterol feeding led to insulin resistance and impaired glucose clearance in B6-PCSK9-HFD-C mice compared with B6-Chow controls. This decrease in metabolic health in B6-PCSK9-HFD-C mice as well as the development of atherosclerosis was similar to Ldlr−/− HFD-C mice. Importantly, HFD-C feeding induced pancreatic islet hyperplasia in B6-PCSK9-HFD-C and B6-HFD-C compared with B6-Chow controls. In line with alterations in the metabolic phenotype, there was an increase in the number of pro-inflammatory Ly6Chigh/med monocytes within the adipose tissues of B6-PCSK9-HFD-C and B6-HFD-C compared with B6-Chow controls. High-fat diet with added cholesterol-fed AAV-PCSK9-injected C57BL/6 mice can serve as a useful model of integrated metabolic syndrome and atherosclerosis that does not require genetic manipulations. Schematic illustration of the study design with notable results. Mice with hypercholesterolemia induced by AAV-PCSK9 injection paired with high-fat diet with added cholesterol (HFD-C) display similar glucose intolerance and insulin resistance profiles compared to non-injected HFD-C fed control mice, despite having advanced atherosclerosis. Notably, AAV-PCSK9 mice fed HFD-C have mimic the metabolic deficiencies compared with popular HFD-C fed Ldlr−/− model of metabolic syndrome and atherosclerosis.